aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2024. All rights reserved.
44 Tehama St, San Francisco, CA 94105
Privacy Policy
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
Ro, founded as Roman Health Medical LLC, is a healthcare technology company based in the United States. Its core mission is to provide accessible and personalized health treatments for adults. Ro offers a comprehensive platform addressing various health needs, including sexual health, smoking cessation, pharmacy services, and weight management. The company focuses on empowering patients and healthcare professionals with convenient and effective solutions to improve overall wellness.
Notable figures affiliated with Ro include its co-founders Zachariah Reitano, Saman Rahmanian, and Rob Schutz. The company has attracted significant investment from prominent venture capital firms such as FirstMark Capital and General Catalyst. Key achievements include expanding its product offerings to cover a wide range of health issues and establishing itself as a trusted provider in the telehealth space. Ro's impact is evident in its ability to deliver personalized healthcare solutions to millions of patients across the United States.
Operating Status
Active
Ownership Type(s)
Venture Capital, Private Equity
Main Product(s)
Healthcare, Pharmacy
Technology
Telemedicine
Tags
Healthtech
Model Types
SaaS, Platform
Revenue Type(s)
Transactional, Recurring
Customer Type(s)
Consumers
Geographic Exposure
United States
When was Ro founded?
Ro was founded in 2017.
Where is Ro’s headquarters located?
Ro’s headquarters is located in New York City, NY, US.
When was Ro’s last funding round?
Ro’s most recent funding round was for $150M (USD) in February 2022.
How many employees does Ro have?
Ro has 889 employees as of Feb 4, 2024.
How much has Ro raised to-date?
As of July 05, 2023, Ro has raised a total of $1B (USD) since Feb 15, 2022.
Add Comparison
Total Raised to Date
$1B
USD
Last Update Feb 15, 2022
Last Deal Details
$150M
USD
Feb 15, 2022
Series Unknown
Total Employees Over Time
889
As of Feb 2024
Ro Address
116 West 23rd Street
4th Floor
New York City,
New York
10011
United States
TechCrunch
Healx, an AI-enabled drug discovery platform for rare diseases, raises $47M
The company also said it has received regulatory clearance to start Phase 2 clinical trials for a new drug in the U.S. later this year. ©...
Aug 1, 2024
Is this the right Ro?
Help us improve our AI - Is this article for the right company?
TechCrunch
Axle Energy’s sprint to decarbonize the grid lights up with $9M seed led by Accel
Axle Energy is a B2B, back-end infrastructure business focused on connecting flexible assets, such as electric vehicles and home batteries,...
Aug 1, 2024
Is this the right Ro?
Help us improve our AI - Is this article for the right company?
TechCrunch
Founder behind social media app IRL charged with fraud
While venture capitalists and the rest of the technorati are off on holiday or attending the Paris Olympics, the U.S. Securities and...
Aug 1, 2024
Is this the right Ro?
Help us improve our AI - Is this article for the right company?
TechCrunch
Applied Carbon’s farm robot turns plant waste into biochar to capture CO2
The startup has raised $21.5 million to build more of its machines and deploy them throughout the U.S. © 2024 TechCrunch. All rights...
Jul 31, 2024
Is this the right Ro?
Help us improve our AI - Is this article for the right company?
TechCrunch
FranShares has a new approach to passive income, letting people invest in franchises for as little as $500
Historically, passive income has been associated with investing in real estate such as rental properties. FranShares is a Chicago-based...
Jul 30, 2024
Is this the right Ro?
Help us improve our AI - Is this article for the right company?
TechCrunch
ZoomInfo alum raises $15M for startup that builds AI sales engineers
Until a year ago, Arjun Pillai had the comfortable yet important role of chief data officer at ZoomInfo, a B2B database company. But the...
Jul 25, 2024
Is this the right Ro?
Help us improve our AI - Is this article for the right company?
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts